RG-2414

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRG-2414
Drug Alias Nameprotein A fragments (Repligen)RG-2414
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionB cells modulatorsImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRepligen Corp
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A